What is Cagrilintide?
Cagrilintide is a long-acting analog of the hormone amylin, studied in preclinical models for its ability to support appetite suppression, weight management, and metabolic regulation. It is part of a new generation of investigational peptides aimed at complementing GLP-1 agonists in obesity and satiety research.
Mechanism of Interest
Cagrilintide binds to the amylin receptor complex in the brain, playing a role in signaling satiety, slowing gastric emptying, and reducing food intake. It is commonly studied alongside GLP-1 analogs for potential synergistic effects in metabolic health models.
Why Researchers Study Cagrilintide
- Studied for appetite regulation and body weight reduction in preclinical models
- Explored in combination with GLP-1 analogs for enhanced metabolic outcomes
- Investigated for its effects on gastric motility and satiety hormones
Note: This product is provided for laboratory research purposes only. It is not intended for human consumption, medical, diagnostic, or therapeutic use.
Reviews
There are no reviews yet.